Recent News

Study: Pro-inflammatory stress response promotes chemotherapy side effects and cancer relapse

Study: Pro-inflammatory stress response promotes chemotherapy side effects and cancer relapse

A team of researchers, including UNC Lineberger's Norman E. Sharpless, MD, has shown that chemotherapy triggers a pro-inflammatory stress response termed cellular senescence, promoting the adverse effects of chemotherapy as well as cancer relapse and metastasis. Eliminating the senescent cells in mice prevented the side effects and relapse.

Study: Pro-inflammatory stress response promotes chemotherapy side effects and cancer relapse - Read More…

Researchers awarded NCI grant to seek new treatments for deadliest adult brain cancer

Researchers awarded NCI grant to seek new treatments for deadliest adult brain cancer

Backed by a three-year, more than $1.8 million grant from the National Cancer Institute, UNC Lineberger researchers Ryan Miller, MD, PhD, and Gary Johnson, PhD, plan to develop better cancer models to identify patterns of drug resistance in glioblastoma.

Researchers awarded NCI grant to seek new treatments for deadliest adult brain cancer - Read More…

 Cost, technology issues are barriers to real-time cancer patient symptom reporting

Cost, technology issues are barriers to real-time cancer patient symptom reporting

In a perspective published in the New England Journal of Medicine, UNC Lineberger member Ethan Basch, MD, MSc, addressed the need for – and the barriers preventing – electronic reporting of patients’ symptoms between visits.

Cost, technology issues are barriers to real-time cancer patient symptom reporting - Read More…

Start-up with UNC ties secures $2.9 million to develop blood test for cancer

Start-up with UNC ties secures $2.9 million to develop blood test for cancer

A start-up company co-founded by UNC Lineberger researcher Andrew Wang, MD, has raised $2.9 million to commercialize a test designed to capture cancer cells circulating in the blood.

Start-up with UNC ties secures $2.9 million to develop blood test for cancer - Read More…